Dec 18, 2025 07:51AM

Dec 18, 2025 07:50AM

Dec 1, 2025 08:05AM

Dec 1, 2025 08:00AM

Nov 19, 2025 02:44PM

Nov 19, 2025 02:42PM

Nov 19, 2025 02:42PM Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”

Nov 13, 2025 08:45AM

Nov 13, 2025 08:45AM

Nov 12, 2025 11:00AM

Nov 11, 2025 09:18AM

Nov 11, 2025 09:18AM

Oct 13, 2025 08:46AM

Oct 13, 2025 08:45AM Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements

Sep 9, 2025 08:00AM

Sep 9, 2025 08:00AM

Jul 14, 2025 08:32AM

Jul 14, 2025 08:30AM

Jul 9, 2025 08:35AM

Jul 9, 2025 08:30AM

Apr 16, 2025 08:00AM Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board

Mar 26, 2025 08:00AM

Mar 24, 2025 08:00AM

Feb 3, 2025 08:02AM

Feb 3, 2025 08:00AM

Jan 13, 2025 08:00AM

Mar 22, 2024 04:05PM

Nov 7, 2023 08:31AM Salarius Pharmaceuticals, Inc. (SLRX) Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program

Nov 7, 2023 08:30AM

Aug 10, 2023 04:05PM

Aug 8, 2023 04:10PM

Aug 8, 2023 04:05PM

Mar 27, 2023 08:30AM

Nov 10, 2022 08:30AM

Aug 8, 2022 08:30AM Salarius Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

May 12, 2022 04:05PM

Mar 10, 2022 04:05PM

Feb 3, 2022 07:30AM

Jan 13, 2022 07:03AM

Jan 13, 2022 07:00AM

Jul 30, 2020 09:28AM

Jul 29, 2020 06:14PM After-Hours Movers 07/29: (HOME) (APA) (PYPL) Higher; (JAKK) (SPPI) (NOW) Lower (more...)

Apr 29, 2020 07:30AM

Mar 23, 2020 04:18PM

Nov 13, 2019 08:00AM

Sep 13, 2019 08:05AM

Sep 13, 2019 08:00AM

Aug 12, 2019 08:16AM

Aug 12, 2019 08:00AM Salarius Pharmaceuticals CEO Issues Letter to Stockholders

Jul 24, 2019 04:05PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All